Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations

Contributed by: PR Newswire

Tags

Qi-biodesign-$75M

More Like This

PR Newswire associated0

Tsingke Shines at Cell & Gene Therapy International 2024

PR Newswire associated0

Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024

2024 Tsingke High-Impact Literature Compilation - Gene Synthesis

Tsingke Successfully Showcases Innovations at BIO-Europe 2024

From left to right: Dr. Kärt Tomberg, CEO & Co-Founder, Dr. Leopold Parts, CTO, Dr. Rebecca Godfrey, COO. (Photo credit: ExpressionEdits)

ExpressionEdits Raises $13M in Seed Funding to Advance Protein Expression Using AI-Driven Intronization Technology

Canton Biologics Completes Over 300 Million Yuan Series C Financing, Led by SDIC Venture Capital

Sequentia Biotech Secures €10million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for clinical, industrial and research applications (Graphic: Sequentia Biotech)

Sequentia Biotech Secures €10million Equity Investment from Seventure Partners and the EIC Fund to Boost Bioinformatic Solutions for Clinical, Industrial and Research Applications

PR Newswire associated0

Eligo Publishes in Nature a Landmark Study That Unlocks Genome Editing of Bacteria in the Gut